TransMedics (TMDX) Cash from Investing Activities (2018 - 2026)

TransMedics has reported Cash from Investing Activities for 9 years, with the latest figure at -$7.1 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 21.85% year-over-year to -$7.1 million in Q2 2026; TTM through Jun 2026 was -$66.9 million, a 31.38% increase from a year earlier, with the FY2025 full-year figure at -$59.3 million, up 54.18% from the prior year.
• Cash from Investing Activities was -$7.1 million for Q2 2026 at TransMedics, up from -$36.7 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $24.7 million in Q3 2022, with the low at -$149.8 million in Q3 2023.
• Average Cash from Investing Activities over 5 years is -$20.7 million, with a median of -$11.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities surged 478.73% in 2022, then slumped 4665.05% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$2.8 million in 2022, then slumped by 1412.95% to -$41.8 million in 2023, then jumped by 67.46% to -$13.6 million in 2024, then decreased by 14.02% to -$15.5 million in 2025, then surged by 54.29% to -$7.1 million in 2026.
• The last three Cash from Investing Activities figures came in at -$7.1 million (Q2 2026), -$36.7 million (Q1 2026), and -$15.5 million (Q4 2025), per Business Quant data.